You’re likely here because you’ve heard that Zantac (also known as ranitidine) has been linked to cancer and existing lawsuits against the makers of Zantac have been filed.
Popular heartburn drug Zantac is being investigated for cancer risks by the US Food and Drug Administration (FDA) after their testing showed that the household heartburn medication contains the presence of a cancer-causing chemical. FDA testing of Zantac 150 tablets revealed the carcinogenic chemical N-nitrosodimethylamine, or NDMA, can be found in the drug and generic versions of the drug at excessively greater amounts than the daily intake limit when tested under the FDA recommended protocols.
Valisure’s research, along with that of Stanford University and others, found that NDMA >was the result of the “inherent instability” of the ranitidine molecule. This means that all manufacturers, brand or generic, and all lots of ranitidine-containing medications are >affected and could generate very high levels of NDMA in the human body.
Current Info on the Zantac Lawsuit and Recall
The Zantac lawsuits are alleging the drugmaker Sanofi and Boehringer Ingelheim manufactured, marketed, and sold a product they knew or should have known had been contaminated with NDMA were filed beginning the same day the Food and Drug Agency first announced its advisory.
A voluntary recall was also issued which led to the removal of Zantac from most drugstores such as Walmart, CVS, and Walgreens.
Although the exact cause of the NDMA contamination is still being investigated, links between Zantac and NDMA have been scientifically demonstrated since the 1980s. When ranitidine, the active ingredient in Zantac, comes into contact with water, a chemical reaction results in the formation of this molecule.
The lawsuit against Sanofi and Boehringer Ingelheim allege that the drug companies chose to conceal this information from the government and with consumers. These lawsuits against Zantac also allege that this lack of disclosure led to many people developing or being placed at risk of developing cancer.
The FDA was first alerted to the presence of NDMA in Zantac in 2019 by the aforementioned Connecticut-based online pharmacy Valisure who discovered that the product contained millions of grams of NDMA more than the FDA established daily intake limit of 96 ng (nanograms).
“We found dramatically high amounts of NDMA.”
Valisure chemically tests every batch of every medication and supplement that we sell.
— Valisure (@valisure) October 2, 2019
“We trust our drug supply but, you know, recent events show issues can arise every once in a while”
— Valisure (@valisure) October 3, 2019
— Valisure (@valisure) September 18, 2019
What is Zantac?
Ranitidine hydrochloride, better known under the commercial name Zantac, is an antacid medication available as both an over the counter drug and by prescription from a physician.
Millions of people use the drug to treat acid reflux, heartburn, Barrett’s esophagus, gastric and duodenal ulcers, gastroesophageal reflux disease (or GERD),and other gastrointestinal issues.
Some consumers may also use it to help with their allergies.
Products That Contain Ranitidine
Although the drug is best known as Zantac, several variations and generic versions have been on the market.
All of the following products contain the active ingredient ranitidine:
- Acid Control (ranitidine)
- Acid Reducer (ranitidine)
- Heartburn Relief (ranitidine)
- Wal-Zan 150
- Wal-Zan 75
- Zantac 150 Maximum Strength
- Zantac 150 Maximum Strength Cool Mint
- Zantac 150 Tablets
- Zantac 75 Tablets
Associated Cancer Risks of Zantac
Cancer risks associated with brand-name Zantac and generic ranitidine include:
- Bladder cancer
- Colon and rectal cancer
- Esophageal cancer
- Intestinal cancer
- Kidney cancer
- Liver cancer
- Lung cancer (non-smokers)
- Ovarian cancer
- Pancreatic cancer
- Prostate cancer
- Stomach cancer
- Testicular cancer
- Thyroid cancer
- Uterine cancer
Zantac Class Action Lawsuit
Class action lawsuits are now being filed which allege that the makers of Zantac profited from the popular perception of a high degree of safety while using the drug. These suits also claim that the drug companies mislead customers about the risks of side effects from using ranitidine products.
The Difference Between a Zantac Class Action Lawsuit & a Zantac Cancer Lawsuit
A Zantac class action lawsuit is filed on behalf of anyone who has purchased Zantac in the past and has not developed cancer. Joining a lawsuit will allow you to recover the money spent purchasing while holding the makers responsible for any alleged wrongdoing.
People who have developed cancer and the family members of those who have died from cancer after using Zantac may be eligible to file a personal injury or wrongful death lawsuit against the manufacturers.
Who Is Eligible to Join the Class Action Lawsuit?
Consumers who have purchased Zantac and can provide a proof of the purchase are eligible to join in the Zantac lawsuit against the makers the drug.
Those who join the Zantac lawsuit will not have to demonstrate they were harmed directly by the medication, only that they purchased the drug without being warned about any possible risk of cancer.
Contact Us If You Have Taken Zantac for 1 Year or Longer
If you or a loved one regularly consumed brand-name Zantac for 1 year or longer, either by prescription or over the counter, contact the Bryant Law Center to discuss your legal options and concerns.
Residents of 4 states – California, Vermont, Massachusetts, and Illinois – may be eligible to join a class action lawsuit if they consumed generic ranitidine.
Zantac Lawsuit Compensation
Since there have been no large settlements regarding the relationship between Zantac and potential link to bladder/stomach cancer we cannot estimate compensation amounts at this time.
Free Case Evaluation
There is no cost for a Zantac case evaluation at The Bryant Law Center. To schedule an appointment, contact The Bryant Law Center at 270-442-1422.
The Bryant Law Center has been representing consumers against harmful pharmaceuticals and drug company mistakes since 1990. We have also represented medical consumers and patients injured by defective medical devices and products including hip replacements, pelvic mesh and several defective drugs and and injuries caused by consumer products. We will regularly update clients on the status of their cases.
If you have regularly used Zantac for 1 year or longer, you may have a claim. Some Zantac claims may be time limited so an expedited consultation enables us to start examining your potential claim immediately.